AND	term1 AND term2	Both terms must be included
OR	term1 OR term2	Either term
NOT	term1 NOT term2	term2 must not appear
""	"term1 term2"	Exact match
()	term1 AND (term2 OR term3)	Grouping terms
?	withdr?w	Single letter wildcard (withdraw, withdrew)
*	withdr*	Multiple letter wildcard (withdraw, withdrawn, withdrawing)
"..."~n	"term1 term2"~n	Proximity (term1 within n words of term2)

Search results

Order by: most recent most popular relevance

Jurisdiction

Work area

Firm name

Date from

Date to

Results:1-10 of 12,051

The Granston Memo in Action: DOJ Announces Intent to Seek Dismissal of FCA Complaints in Key Cases

Steptoe & Johnson LLP
USA
January 17 2019

In a motion filed in the US District Court for the Eastern District of Texas in late 2018, the US Department of Justice (DOJ) sought to dismiss 11

“Fake Meat” Discussed at Farm Bureau Federation Annual Meeting

Duane Morris LLP
USA
January 17 2019

The American Farm Bureau Federation (AFBF), a prominent non-governmental organization in the U.S. representing farm and ranch families, held its

In Case You Missed It: A List of Our Health Care Year in Review Posts

Mintz
USA
January 17 2019

Over the last few weeks, we published a number of posts examining important developments and trends in 2018 as well as what we expect to see in 2019

Ninth Circuit Affirms Federal Preemption Over Dietary Supplement Claims

Reed Smith LLP
USA
January 17 2019

We have taken a daily multivitamin ever since our doctor told us that we were chronically deficient in a particular vitamin, the one you can get from

FDA Resumes Inspections of High-Risk Food Facilities

Keller and Heckman LLP
USA
January 16 2019

As previously reported on this blog, the partial federal government shutdown stalled FDA’s ability to conduct routine inspections of domestic food

FDA Issues Guidance Documents on the “Deemed to be a License” Transition Provision of the BPCIA

Rothwell, Figg, Ernst & Manbeck, PC
USA
January 16 2019

The Biologics Price Competition and Innovation Act (“BPCIA”) requires applications to market a biological product be submitted for review by the FDA

FDA Proposes to Clarify and Formalize the De Novo Classification Process for Medical Devices

Epstein Becker Green
USA
January 16 2019

On December 7, 2018, the U.S. Food and Drug Administration (“FDA”) published a proposed rule (“Proposed Rule”) that, if finalized, would clarify the

Blumenauer Introduces the “Regulate Marijuana Like Alcohol Act”

Burns & Levinson LLP
USA
January 16 2019

As described in last week’s post, 2018 proved to be an exceptionally exciting year for the cannabis industry: five states approved legalization

Washington Healthcare Update- Jan 15, 2019

McGuireWoods Consulting LLC
USA
January 15 2019

This Week: As of today, the government has been partially shut down for 25 days, surpassing the longest federal government shutdown in history during

The Final Score: 2018 Drug & Biologic Patent Approvals

Dilworth IP
USA
January 15 2019

The past year was a big year for FDA approved new drugs and biologics - 59 in fact, compared to 46 in 2017 and a mere 22 in 2016. From the published

Search techniques

Current Search

Refine

Content type

Tags